Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
Joseph TopalNeelam PanchalAmairelys BarroetaAnna RoppeltAnnelotte MuddeH Bobby GasparAdrian J ThrasherBenjamin C HoughtonClaire BoothPublished in: Journal of clinical immunology (2022)
Gene correction of HSCs recovers XIAP-dependent immune defects and could offer a treatment option for patients with XIAP deficiency.